Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

【导读】这项研究评估了鞘内培美曲塞（IP）对既往接受过治疗的表皮生长因子受体（EGFR）突变晚期非小细胞肺癌（NSCLC）患者脑膜转移瘤（LM）的治疗效果。2024年12月7日，中南大学湘雅医学院附属肿瘤医院张永昌教授团队在期刊《Heliyon》上发 ...

Revenue generated from pharma research and development services was RMB24.9 million (US$3.5 million) for the three months ...

No one under the age of 25 knows Match of the Day without Gary Lineker. A TV era is ending with the Saturday night hot seat being vacated when the Premier League season ends in May, Sky News has ...

compared to the months required before NGS. A recent study 2 recommended dedicated ophthalmic screening for all children at risk for retinoblastoma above the general population’s risk. The frequency ...

Genetic disorders are diseases caused by an abnormal gene, often described as a mutation. When such diseases are inherited (rather than the result of a random mutation), it means they are passed along ...

Impact: * Molecular markers like EGFR mutations, ALK, and ROS1 rearrangements are key targets for treatment in NSCLC, with approved drugs available for these alterations. * Next-generation sequencing ...

Molecular markers like EGFR mutations, ALK, and ROS1 rearrangements are key targets for treatment in NSCLC, with approved drugs available for these alterations. Next-generation sequencing (NGS ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC).

Genomic testing performed on tumor samples or through liquid biopsy, identifies genetic mutations or alterations such as EGFR, ALK, ROS1, BRAF, KRAS, and others through the Next Generation sequencing ...

Call it the next frontier in machine learning: scientists have designed a large language model, Evo, to interpret biological sequence data or genetic code. To pivot AI in the direction of biology ...